Hiroki Kato

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 10

Top Topics

Gold Nanoparticles

Recombinant Human

Positron Emission Tomography

Top Venues

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Diagnostics (Basel, Switzerland)

Journal of nanobiotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Xuhao Huang, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuya Kabayama, Atsushi Shimoyama, Kazuhiro Ooe, Hiroki Kato, Atsushi Toyoshima, Atsushi Shinohara, Hiromitsu Haba, Yang Wang, Koichi Fukase
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection. Pharmaceutics 14 (12) (2022)
Mirei Watanabe, Hiroki Kato, Daisuke Katayama, Fumihiko Soeda, Keiko Matsunaga, Tadashi Watabe, Mitsuaki Tatsumi, Eku Shimosegawa, Noriyuki Tomiyama
Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose-positron emission tomography to differentiate between benign and malignant lesions. Annals of nuclear medicine 36 (11) (2022)
Hiroki Kato, Jyoji Nakagawara, Kenji Hachisuka, Jun Hatazawa, Katsunori Ikoma, Eiichi Suehiro, Hidehiko Iida, Kuniaki Ogasawara, Osamu Iizuka, Sumio Ishiai, Tadashi Ichikawa, Tadashi Nariai, Tetsuya Okazaki, Tohru Shiga, Etsuro Mori
Impaired neuronal integrity in traumatic brain injury detected by 123 I-iomazenil single photon emission computed tomography and MRI. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 42 (12) (2022)
Xuhao Huang, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuya Kabayama, Atsushi Shimoyama, Kazuhiro Ooe, Hiroki Kato, Atsushi Toyoshima, Atsushi Shinohara, Hiromitsu Haba, Yang Wang, Koichi Fukase
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection. Pharmaceutics 14 (12) (2022)
Xuhao Huang, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuya Kabayama, Atsushi Shimoyama, Kazuhiro Ooe, Hiroki Kato, Atsushi Toyoshima, Atsushi Shinohara, Hiromitsu Haba, Yang Wang, Koichi Fukase
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection. Pharmaceutics 14 (12) (2022)
Xuhao Huang, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuya Kabayama, Atsushi Shimoyama, Kazuhiro Ooe, Hiroki Kato, Atsushi Toyoshima, Atsushi Shinohara, Hiromitsu Haba, Yang Wang, Koichi Fukase
Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection. Pharmaceutics 14 (12) (2022)
Hiroki Kato, Xuhao Huang, Yuichiro Kadonaga, Daisuke Katayama, Kazuhiro Ooe, Atsushi Shimoyama, Kazuya Kabayama, Atsushi Toyoshima, Atsushi Shinohara, Jun Hatazawa, Koichi Fukase
Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy. Journal of nanobiotechnology 19 (1) (2021)
Kosuke Mitsuyuki, Tadashi Watabe, Sadahiro Naka, Yuwei Liu, Mitsuaki Tatsumi, Eku Shimosegawa, Hiroki Kato
Evaluation of Integrin αvβ3 Expression in Murine Xenograft Models: [68Ga]Ga-DOTA-C(RGDfK) PET Study with Immunohistochemical Confirmation. Diagnostics (Basel, Switzerland) 11 (7) (2021)
Seiji Mabuchi, Naoko Komura, Tomoyuki Sasano, Kotaro Shimura, Eriko Yokoi, Katsumi Kozasa, Hiromasa Kuroda, Ryoko Takahashi, Mahiru Kawano, Yuri Matsumoto, Hiroki Kato, Jun Hatazawa, Tadashi Kimura
Pretreatment tumor-related leukocytosis misleads positron emission tomography-computed tomography during lymph node staging in gynecological malignancies. Nature communications 11 (1) (2020)
Hiroki Kato, Kayako Isohashi, Eku Shimosegawa, Jun Hatazawa
Increase in extraction of I-123 iomazenil in patients with chronic cerebral ischemia. PloS one 13 (1) (2018)